Download PDF
Thromb Haemost 2010; 103(04): 860-862
DOI: 10.1160/TH09-08-0577
Letters to the Editor
Schattauer GmbH

Cellular and intracellular distribution of recombinant activated factor VII in the rat liver

Torben Seested
1   Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark
2   Exploratory ADME, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark
,
Hanne M. Nielsen
1   Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark
,
Erik I. Christensen
3   Department of Anatomy, Section of Cell Biology, Aarhus University, Aarhus C, Denmark
,
Rupa S. Appa
2   Exploratory ADME, Biopharmaceutical Research Unit, Novo Nordisk A/S, Måløv, Denmark
› Author Affiliations
Further Information

Publication History

Received: 19 August 2009

Accepted after major revision: 22 February 2009

Publication Date:
15 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Kavakli K, Makris M, Zulfikar B. et al. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial. Thromb Haemost 2006; 95: 600-605.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2004; 02: 899-909.
    CrossrefPubMedGoogle Scholar
  • 3 Fuchs HE, Trapp HG, Griffith MJ. et al. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors. J Clin Invest 1984; 73: 1696-1703.
    CrossrefPubMedGoogle Scholar
  • 4 Fuchs HE, Pizzo SV. Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors. J Clin Invest 1983; 72: 2041-2049.
    CrossrefPubMedGoogle Scholar
  • 5 Narita M, Rudolph AE, Miletich JP. et al. The low-density lipoprotein receptor-related protein (LRP) mediates clearance of coagulation factor Xa in vivo. Blood 1998; 91: 555-560.
    PubMedGoogle Scholar
  • 6 Rao LV, Pendurthi UR. Regulation of tissue factor-factor VIIa expression on cell surfaces: a role for tissue factor-factor VIIa endocytosis. Mol Cell Biochem 2003; 253: 131-140.
    CrossrefPubMedGoogle Scholar
  • 7 Ghosh S, Pendurthi UR, Steinoe A. et al. Endothelial Cell Protein C Receptor Acts as a Cellular Receptor for Factor VIIa on Endothelium. J Biol Chem 2007; 282: 11849-11857.
    CrossrefPubMedGoogle Scholar
  • 8 Chang GT, Kisiel W. Internalization and degradation of recombinant human coagulation factor VIIa by the human hepatoma cell line HuH7. Thromb Haemost 1995; 73: 231-238.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Hjortoe G, Sorensen BB, Petersen LC. et al. Factor VIIa binding and internalization in hepatocytes. J Thromb Haemost 2005; 03: 2264-2273.
    CrossrefPubMedGoogle Scholar
  • 10 Thomsen MK, Diness V, Nilsson P. et al. Pharmacokinetics of recombinant factor VIIa in the rat--a comparison of bio-, immuno- and isotope assays. Thromb Haemost 1993; 70: 458-464.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Beeby TL, Chasseaud LF, Taylor T. et al. Distribution of the recombinant coagulation factor 125I-rFVIIa in rats. Thromb Haemost 1993; 70: 465-468.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Tranholm M, Kristensen K, Kristensen AT. et al. Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A. Blood 2003; 102: 3615-3620.
    CrossrefPubMedGoogle Scholar
  • 13 Lauritzen B, Hedner U, Johansen PB. et al. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats. J Thromb Haemost 2008; 06: 804-811.
    CrossrefPubMedGoogle Scholar
  • 14 Gettins PGW. Serpin Structure, Mechanism, and Function. Chem Rev 2002; 102: 4751-4804.
    CrossrefPubMedGoogle Scholar
  • 15 Petersen LC, Elm T, Ezban M. et al. Plasma elimination kinetics for factor VII are independent of its activation to factor VIIa and complex formation with plasma inhibitors. Thromb Haemost 2009; 101: 818-826.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Strickland DK, Medved L. Low-density lipoprotein receptor-related protein (LRP)-mediated clearance of activated blood coagulation co-factors and pro-teases: clearance mechanism or regulation?. J Thromb Haemost 2006; 04: 1484-1486.
    CrossrefPubMedGoogle Scholar
  • 17 Kounnas MZ, Church FC, Argraves WS. et al. Cellular Internalization and Degradation of Antithrombin III-Thrombin, Heparin Cofactor II-Thrombin, and alpha(1)-Antitrypsin-Trypsin Complexes Is Mediated by the Low Density Lipoprotein Receptor-related Protein. J Biol Chem 1996; 271: 6523-6529.
    CrossrefPubMedGoogle Scholar
  • 18 Strickland DK, Kounnas MZ. Mechanisms of Cellular Uptake of Thrombin-Antithrombin II Complexes Role of the Low-Density Lipoprotein Receptor-Related Protein as a Serpin-Enzyme Complex Receptor. Trends Cardiovasc Med 1997; 07: 9-16.
    CrossrefPubMedGoogle Scholar
  • 19 Wells MJ, Sheffield WP, Blajchman MA. The clearance of thrombin-antithrombin and related serpin-enzyme complexes from the circulation: role of various hepatocyte receptors. Thromb Haemost 1999; 81: 325-337.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Jurlander B, Thim L, Klausen NK. et al. Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development. Semin Thromb Hemost 2001; 27: 373-384.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem 1982; 51: 531-554.
    CrossrefPubMedGoogle Scholar
  • 22 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-1097.
    PubMedGoogle Scholar
  • 23 Fleck RA, Rao LV, Rapaport SI. et al. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59: 421-437.
    CrossrefPubMedGoogle Scholar
  • 24 Hansen CB, Pyke C, Petersen LC. et al. Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor. Blood 2001; 97: 1712-1720.
    CrossrefPubMedGoogle Scholar
  • 25 Iakhiaev A, Pendurthi UR, Rao LV. Active site blockade of factor VIIa alters its intracellular distribution. J Biol Chem 2001; 276: 45895-45901.
    CrossrefPubMedGoogle Scholar
  • 26 Thomsen MK, Diness V, Nilsson P. et al. Pharmacokinetics of recombinant factor VIIa in the rat--a comparison of bio-, immuno- and isotope assays. Thromb Haemost 1993; 70: 458-464.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Christensen EI, Nielsen S, Moestrup SK. et al. Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. Eur J Cell Biol 1995; 66: 349-364.
    PubMedGoogle Scholar